Improving testing for hepatitis B before treatment with rituximab.
about
Ocrelizumab and Other CD20(+) B-Cell-Depleting Therapies in Multiple Sclerosis.Randomized prospective study evaluating tenofovir disoproxil fumarate prophylaxis against hepatitis B virus reactivation in anti-HBc-positive patients with rituximab-based regimens to treat hematologic malignancies: The Preblin study.Human herpes virus-6 encephalitis causing severe anterograde amnesia associated with rituximab, azathioprine and prednisolone combination therapy for dermatomyositis.Practice Patterns in Hepatitis B Virus Screening Before Cancer Chemotherapy in a Major US Hospital Network.
P2860
Improving testing for hepatitis B before treatment with rituximab.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 July 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Improving testing for hepatitis B before treatment with rituximab.
@en
Improving testing for hepatitis B before treatment with rituximab.
@nl
type
label
Improving testing for hepatitis B before treatment with rituximab.
@en
Improving testing for hepatitis B before treatment with rituximab.
@nl
prefLabel
Improving testing for hepatitis B before treatment with rituximab.
@en
Improving testing for hepatitis B before treatment with rituximab.
@nl
P2093
P2860
P1476
Improving testing for hepatitis B before treatment with rituximab.
@en
P2093
Jayne Harwood
Jessica K Dyson
Laura Jopson
Manoj Valappil
Matthew Lowery
Sheila Waugh
P2860
P304
P356
10.1097/MEG.0000000000000689
P577
2016-07-06T00:00:00Z